A CONTROLLED TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER TOTAL-BODY IRRADIATION, HIGH-DOSE CHEMOTHERAPY, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA OR MALIGNANT-LYMPHOMA

被引：0
|
作者：
LINK, H
BOOGAERTS, MA
CARELLA, AM
FERRANT, A
GADNER, H
GORIN, NC
HARABACZ, I
HAROUSSEAU, JL
HERVE, P
HOLLDACK, J
KOLB, HJ
KRIEGER, O
LABAR, B
LINKESCH, W
MANDELLI, F
MARANINCHI, D
NAPARSTEK, E
NICOLAY, U
NIEDERWIESER, D
REIFFERS, J
RIZZOLI, V
SIEGERT, W
VERNANT, JP
DEWITTE, T
机构：
[1] CATHOLIC UNIV LEUVEN, MED CTR, DEPT HEMATOL, B-3000 LOUVAIN, BELGIUM
[2] OSPED SAN MARTINO GENOVA, DEPT HEMATOL, GENOA, ITALY
[3] CLIN UNIV ST LUC, DEPT HEMATOL, B-1200 BRUSSELS, BELGIUM
[4] ST ANNA CHILDRENS HOSP, DEPT PEDIAT HEMATOL & ONCOL, VIENNA, AUSTRIA
[5] HOP ST ANTOINE, DEPT HEMATOL, F-75571 PARIS 12, FRANCE
[6] HOP HOTEL DIEU, DEPT HEMATOL, NANTES, FRANCE
[7] UNIV BESANCON, MED CTR, DEPT HEMATOL, F-25030 BESANCON, FRANCE
[8] UNIV MUNICH, MED CTR, DEPT HEMATOL, W-8000 MUNICH 2, GERMANY
[9] HANUSCH HOSP, DEPT LEUKEMIA RES & HEMATOL, VIENNA, AUSTRIA
[10] UNIV ZAGREB, MED CTR, DEPT HEMATOL, YU-41001 ZAGREB, CROATIA
[11] UNIV VIENNA, MED CTR, DEPT HEMATOL, A-1010 VIENNA, AUSTRIA
[12] UNIV ROME LA SAPIENZA, POLICLIN UMBERTO 1, DEPT HEMATOL, I-00185 ROME, ITALY
[13] INST J PAOLI I CALMETTES, DEPT HEMATOL, F-13009 MARSEILLE, FRANCE
[14] HADASSAH UNIV HOSP, DEPT BONE MARROW TRANSPLANTAT, JERUSALEM, ISRAEL
[15] UNIV INNSBRUCK, MED CTR, DEPT IMMUNOBIOL, A-6020 INNSBRUCK, AUSTRIA
[16] HOP HAUT LEVEQUE, DEPT HEMATOL, PESSAC, ITALY
[17] UNIV PARMA, MED CTR, DEPT HEMATOL, I-43100 PARMA, ITALY
[18] FREE UNIV BERLIN, KLINIKUM CHARLOTTENBURG, MED CTR, DEPT HEMATOL & ONCOL, W-1000 BERLIN 19, GERMANY
[19] HOP HENRI MONDOR, DEPT HEMATOL, F-94010 CRETEIL, FRANCE
[20] CATHOLIC UNIV NIJMEGEN, MED CTR, DEPT HEMATOL, NIJMEGEN, NETHERLANDS
[21] BEHRINGWERKE AG, W-3550 MARBURG, GERMANY
来源：
BLOOD | 1992年 / 80卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2188 / 2195
页数：8
相关论文
共 50 条
  • [41] TOTAL-BODY IRRADIATION AND MAXIMUM DOSE VP 16 FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LYMPHOBLASTIC-LEUKEMIA AND LYMPHOMA
    SCHMITZ, N
    GASSMANN, W
    RISTER, M
    SUTTORP, M
    LOFFLER, H
    BLUT, 1988, 57 (04): : 214 - 214
  • [42] BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA AND LYMPHOMA WITH HIGH-DOSE CYTOSINE-ARABINOSIDE AND TOTAL-BODY IRRADIATION
    HERZIG, RH
    COCCIA, PF
    STRANDJORD, SE
    WARKINTIN, PI
    CHEUNG, NK
    GORDON, EM
    NOVAK, L
    SHINA, D
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 139 - 140
  • [43] BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA AND LYMPHOMA WITH HIGH-DOSE CYTOSINE-ARABINOSIDE AND TOTAL-BODY IRRADIATION
    HERZIG, RH
    COCCIA, PF
    LAZARUS, HM
    STRANDJORD, SE
    GRAHAMPOLE, J
    CHEUNG, NK
    GORDON, EM
    GROSS, S
    SPITZER, TR
    WARKENTIN, PI
    FAY, JW
    PHILLIPS, GL
    HERZIG, GP
    SEMINARS IN ONCOLOGY, 1985, 12 (02) : 184 - 186
  • [44] BIOSYNTHETIC (RECOMBINANT) HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - EFFECT ON NORMAL BONE-MARROW AND LEUKEMIA-CELL LINES
    TOMONAGA, M
    GOLDE, DW
    GASSON, JC
    BLOOD, 1986, 67 (01) : 31 - 36
  • [45] NEUTROPHIL MIGRATION IS DEFECTIVE DURING RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR INFUSION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HUMANS
    PETERS, WP
    STUART, A
    AFFRONTI, ML
    KIM, CS
    COLEMAN, RE
    BLOOD, 1988, 72 (04) : 1310 - 1315
  • [46] RECOMBINANT HUMAN INTERLEUKIN-3 AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED INVIVO AFTER HIGH-DOSE CYCLOPHOSPHAMIDE CANCER-CHEMOTHERAPY - EFFECT ON HEMATOPOIESIS AND MICROENVIRONMENT IN HUMAN BONE-MARROW
    ORAZI, A
    CATTORETTI, G
    SCHIRO, R
    SIENA, S
    BREGNI, M
    DINICOLA, M
    GIANNI, AM
    BLOOD, 1992, 79 (10) : 2610 - 2619
  • [47] Use of recombinant human granulocyte colony-stimulating factor prior to autologous bone marrow transplantation in dogs with lymphoma
    Lane, Amy E.
    Chan, Marisa J. Y.
    Wyatt, Kenneth M.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2012, 73 (06) : 894 - 899
  • [48] RANDOMIZED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HIGH-RISK LYMPHOID MALIGNANCIES
    STAHEL, RA
    JOST, LM
    CERNY, T
    PICHERT, G
    HONEGGER, H
    TOBLER, A
    JACKY, E
    FEY, M
    PLATZER, E
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) : 1931 - 1938
  • [49] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOID CANCER - AN ECONOMIC-ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    LUCE, BR
    SINGER, JW
    WESCHLER, JM
    BUCKNER, CD
    SHEINGOLD, SH
    SHANNONDORCY, K
    APPELBAUM, FR
    NEMUNAITIS, J
    PHARMACOECONOMICS, 1994, 6 (01) : 42 - 48
  • [50] EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS ON NEUTROPHIL FUNCTION FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    GADISH, M
    KLETTER, Y
    FLIDEL, O
    NAGLER, A
    SLAVIN, S
    FABIAN, I
    LEUKEMIA RESEARCH, 1991, 15 (12) : 1175 - 1182
12345